Turkish Archives of Pediatrics
Case-Based Review

Neurofibromatosis Type I and Hodgkin Lymphoma: Case Report and Review of the Literature


Division of Pediatric Hematology-Oncology, Oncology Institute, Itanbul University, Iİstanbul, Turkey

Turk Arch Pediatr 2022; 57: 566-568
DOI: 10.5152/TurkArchPediatr.2022.22004
Read: 597 Downloads: 287 Published: 01 September 2022

Objective: Neurofibromatosis 1 is an autosomal dominant inherited tumor susceptibility syndrome. Individuals with neurofibromatosis 1 have a 4-5 times increased risk of malignancy compared to the general population. Central nervous system and soft tissue tumors are common non-hematological malignancies in individuals with neurofibromatosis 1. Although the association of leukemia and non-Hodgkin lymphoma as hematologic malignancies in neurofibromatosis 1 has been reported frequently in the literature in these individuals, association with Hodgkin lymphoma has been reported very rarely.

Materials and Methods: We presented a patient with neurofibromatosis 1 who further developed Hodgkin lymphoma and reviewed the literature.

Conclusion: Although rare, Hodgkin lymphoma can develop in individuals with neurofibromatosis 1. Hodgkin lymphoma should be kept in mind in cervical/supraclavicular lymphadenomegalies when evaluating patients with neurofibromatosis 1.

Cite this article as: Yıldırım ÜM, Kebudi R. Neurofibromatosis type I and hodgkin lymphoma: case report and review of the literature. Turk Arch Pediatr. 2022;57(5):566-568.

EISSN 2757-6256